Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8653187 | Annals of Vascular Surgery | 2018 | 15 Pages |
Abstract
The results of our study suggest that the presence of malignancy does not affect short-term outcomes of endovascular thrombolytic therapy in symptomatic DVT. Further follow-up is needed to evaluate long-term outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
William J. Yoon, Pegge Halandras, Bernadette Aulivola, Paul Crisostomo,